Compound ID | 258
Class: 6-anilinouracil-fluoroquinolone hybrid
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Inhibitors of pol IIIC and Topoisomerase IV; effective against 6-anilinouracils or fluoroquinolone resistant Gram positive bacteria |
| Institute where first reported: | Microbiotix, US; GLSynthesis, USA |
| Year first mentioned: | 2003 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |